Latest news
Immunocore reports second quarter financial results and provides a business update - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 04:14:05 GMTIN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:01:00 GMTLeading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTSonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers - AstraZenecaAstraZeneca · Mon, 27 Jul 2026 07:00:00 GMT